Neuro-Oncology Nugget: Phase 1/2 BT008NA Trial — Focused Ultrasound + Temozolomide for High-Grade Glioma
Host/Interviewee: Shahad Abdulsahib, PhD Graduate, UT Health San Antonio Description: Shahad Abdulsahib discusses the phase 1/2 BT008NA clinical trial evaluating microbubble-enhanced transcranial focused ultrasound combined with temozolomide in patients with newly diagnosed high-grade glioma, with findings published in The Lancet Oncology in December 2025
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Neuro-Oncology: The Podcast
Hot Topics: Wellness in Neuro-oncology
SNObound: Career description and advice from Dr. Ryan Cecchi in Neuropathology
CATNON Conclusion: Closure on concurrent chemotherapy in IDHmt Grade 3 Astrocytoma
Hot Topics: What's next in neuro-oncology
Get summaries like this every morning.
Free AI-powered recaps of Neuro-Oncology: The Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.